Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.
ESMO Open
; 7(3): 100475, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35490579
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Female
/
Humans
Language:
En
Journal:
ESMO Open
Year:
2022
Document type:
Article
Country of publication: